Journal
EMERGING INFECTIOUS DISEASES
Volume 15, Issue 3, Pages 415-422Publisher
CENTERS DISEASE CONTROL & PREVENTION
DOI: 10.3201/eid1503.080312
Keywords
-
Categories
Funding
- Sage Products, Inc. (Cary, IL, USA).
Ask authors/readers for more resources
identifying patients who are at high risk for severe Clostridium difficile-associated disease (CDAD) early in the course of their infection may help clinicians improve outcomes. Therefore, we compared clinical features associated with severe versus nonsevere CDAD by retrospectively reviewing records of hospitalized patients whose fecal assays were positive for C. difficile toxin. Of 336 patients, 12.2% had severe disease and 10.1% died from all causes. Regression modeling showed the following to be significantly associated with severe CDAD (p <= 0.05): age > 70 years (odds ratio [OR] 3.35), maximum leukocyte count > 20,000 cells/mL (OR 2.77), minimum albumin level < 2.5 g/dL (OR 3.44), maximum creatinine level > 2 mg/dL (OR 2.47), small bowel obstruction or ileus (OR 3.06), and compute tomography scan showing colorectal inflammation (OR 13.54). may be useful for identifying patients at risk for serious outcomes or death.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available